Merrell Pharmaceuticals Inc competitors

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Country Manager enabling teams to deliver the present and charter the future aspirations, setting vision, strategising to capitalise on emerging opportunities in India and South Asian regions. P&L leader with multiple TA domain expertise, and across geographies in leading MNC,Indian companies with cultural diversity. Expertise in healthcare Sales& Marketing, Strategy, Business operations, new business venture management, strategic planning, managing acquisition, strategic alliance management, and International Business ( Includes Indian subcontinent of Srilanka, Bangladesh, Pakistan, Maldives etc), and exposure across AP markets. Expertise in leading profitable growth at South west Asia cluster country level. specialty,chronic and mass base business units across leading MNC & Indian companies.Setting up of Key Account Management and international business.